#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	16498	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2311	711.4	0	.	n	.	0	C207T	SNP	207	207	C	569	569	T	893	T,C	638,160	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	16498	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2311	711.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1546	1546	C	931	C	875	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29802	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3633	818.6	0	.	n	.	0	T695C	SNP	695	695	T	1070	1070	C	991	C,A	935,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29802	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3633	818.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2346	2346	C	897	C	833	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29802	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3633	818.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2420	2420	A	894	A,G	836,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29802	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3633	818.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2972	2972	C	897	C,T	842,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2156	folP	855	855	100.0	folP.l15.c17.ctg.1	1333	160.2	1	SNP	p	R229S	1	.	.	685	687	AGC	917	919	AGC	241;242;244	A,C;G;C	225,1;229;229	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5378	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3351	159.8	1	SNP	p	S91F	1	.	.	271	273	TTC	541	543	TTC	183;184;182	T;T;C	168;171;170	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5378	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3351	159.8	1	SNP	p	D95G	1	.	.	283	285	GGC	553	555	GGC	184;182;179	G;G;C	171;165;163	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5378	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3351	159.8	1	SNP	p	G95N	0	.	.	283	285	GGC	553	555	GGC	184;182;179	G;G;C	171;165;163	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1792	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1285	138.9	1	SNP	p	G45D	0	.	.	133	135	GGC	421	423	GGC	210;213;214	G;G;C	202;203;204	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	900	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1023	87.5	0	.	n	.	0	A197.	DEL	197	197	A	599	599	A	206	A	195	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5598	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2889	192.7	1	SNP	p	D86N	0	.	.	256	258	GAC	551	553	GAC	243;245;247	G;A;C	226;219;229	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5598	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2889	192.7	1	SNP	p	S87R	1	.	.	259	261	CGT	554	556	CGT	247;247;250	C;G;T	230;226;226	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5598	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2889	192.7	1	SNP	p	R87W	0	.	.	259	261	CGT	554	556	CGT	247;247;250	C;G;T	230;226;226	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5598	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2889	192.7	1	SNP	p	R87I	0	.	.	259	261	CGT	554	556	CGT	247;247;250	C;G;T	230;226;226	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5598	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2889	192.7	1	SNP	p	S88P	0	.	.	262	264	TCC	557	559	TCC	249;255;253	T;C;C	230;235;237	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4772	parE	1986	1986	100.0	parE.l15.c30.ctg.1	2634	180.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1557	1559	GGC	219;218;217	G;G;C	203;199;201	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4598	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2311	197.8	1	SNP	p	A311V	0	.	.	931	933	GCC	1240	1242	GCC	256;258;257	G;C;C	240;241;241	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4598	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2311	197.8	1	SNP	p	I312M	1	.	.	934	936	ATG	1243	1245	ATG	258;256;259	A;T;G	242;238;235	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4598	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2311	197.8	1	SNP	p	V316T	1	.	.	946	948	ACC	1255	1257	ACC	261;262;264	A;C,T;C	236;237,1;238	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4598	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2311	197.8	1	SNP	p	T316P	0	.	.	946	948	ACC	1255	1257	ACC	261;262;264	A;C,T;C	236;237,1;238	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4598	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2311	197.8	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1756	1758	ACC	240;237;234	A;C;C,T	213;215;215,1	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4598	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2311	197.8	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1810	1812	GCG	270;268;270	G;C;G	251;247;252	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4598	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2311	197.8	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1810	1812	GCG	270;268;270	G;C;G	251;247;252	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4598	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2311	197.8	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1933	1935	GGT	196;197;199	G;G;T	177;175;179	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4598	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2311	197.8	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1942	1944	AGC	195;190;188	A;G;C	170;166;163	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4598	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2311	197.8	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1960	1962	CCG	168;170;167	C,G;C,G;G	130,6;134,1;136	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6260	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3139	198.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1681	1683	CCG	235;235;240	C;C;G	202;214;209	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2174	porA	1146	1146	99.91	porA.l6.c30.ctg.1	1773	121.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	615	615	C	179	C	162	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3374	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1578	212.1	0	.	p	.	0	I45V	NONSYN	133	135	ATT	420	422	GTT	283;280;283	G;T;T	262;258;259	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3374	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1578	212.1	1	SNP	p	G120K	1	.	.	358	360	AAG	645	647	AAG	274;272;270	A;A;G	261;261;256	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3374	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1578	212.1	1	SNP	p	N121D	0	.	.	361	363	AAC	648	650	AAC	275;276;274	A,G;A;C,A	262,1;263;264,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3374	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1578	212.1	1	SNP	p	A121N	1	.	.	361	363	AAC	648	650	AAC	275;276;274	A,G;A;C,A	262,1;263;264,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	12656	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	4882	258.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1316	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1109	118.1	1	SNP	p	V57M	1	.	.	169	171	ATG	525	527	ATG	272;275;276	A;T;G,A	251;252;252,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
